Epigenetic regulation of the Warburg effect by H2B monoubiquitination

• Published in: Cell death and differentiation 2020-05, Vol.27 (5), p.1660-1676
• Main Authors: Jing, Yuan-Ya, Cai, Feng-Feng, Zhang, Lei, Han, Jing, Yang, Lu, Tang, Fan, Li, Ya-Bin, Chang, Jian-Feng, Sun, Feng, Yang, Xiao-Mei, Sun, Fang-Lin, Chen, Su
• Format: Article
• Language: English
• Subjects: 13/1; 13/89; 14/19; 14/63; 42/109; 631/337/176; 631/67/2327; 64/60; 82/51; Animals; Apoptosis; Biochemistry; Biomedical and Life Sciences; Carcinogenesis - genetics; Carcinogenesis - pathology; Carrier Proteins - metabolism; Cell Biology; Cell Cycle Analysis; Cell Line, Tumor; Cell proliferation; Cell Proliferation - genetics; Cell Respiration - genetics; Epigenesis, Genetic; Epigenetics; Glycolysis; HEK293 Cells; Histone H2B; Histones - metabolism; Humans; Kinases; Life Sciences; Lung cancer; Male; Membrane Proteins - metabolism; Metabolism; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Mitochondria - genetics; Molecular Docking Simulation; Oxidative phosphorylation; Phosphorylation; Protein Binding; Pyruvate kinase; Pyruvic acid; Stem Cells; Therapeutic applications; Therapeutic targets; Thyroid Hormone-Binding Proteins; Thyroid Hormones - metabolism; Tumorigenesis; Ubiquitin-Protein Ligases - metabolism; Ubiquitination; Warburg Effect, Oncologic; Xenografts
• ISSN: 1350-9047; 1476-5403
• DOI: 10.1038/s41418-019-0450-2

Cancer cells reprogram their energy metabolic system from the mitochondrial oxidative phosphorylation (OXPHOS) pathway to a glucose-dependent aerobic glycolysis pathway. This metabolic reprogramming phenomenon is known as the Warburg effect, a significant hallmark of cancer. However, the detailed mechanisms underlying this event or triggering this reprogramming remain largely unclear. Here, we found that histone H2B monoubiquitination (H2Bub1) negatively regulates the Warburg effect and tumorigenesis in human lung cancer cells (H1299 and A549 cell lines) likely through controlling the expression of multiple mitochondrial respiratory genes, which are essential for OXPHOS. Moreover, our work also suggested that pyruvate kinase M2 (PKM2), the rate-limiting enzyme of glycolysis, can directly interact with H2B in vivo and in vitro and negatively regulate the level of H2Bub1. The inhibition of cell proliferation and nude mice xenograft of human lung cancer cells induced by PKM2 knockdown can be partially rescued through lowering H2Bub1 levels, which indicates that the oncogenic function of PKM2 is achieved, at least partially, through the control of H2Bub1. Furthermore, PKM2 and H2Bub1 levels are negatively correlated in cancer specimens. Therefore, these findings not only provide a novel mechanism triggering the Warburg effect that is mediated through an epigenetic pathway (H2Bub1) but also reveal a novel metabolic regulator (PKM2) for the epigenetic mark H2Bub1. Thus, the PKM2-H2Bub1 axis may become a promising cancer therapeutic target.